Advertisements


ISS Backs Cigna-Express Scripts Deal

Proxy-advisory firm Institutional Shareholder Services is recommending that Cigna shareholders support the company’s $54 billion deal to buy pharmacy-benefit manager Express Scripts in a vote later this month......»»

Category: smallbizSource: wsjAug 10th, 2018

ISS Backs Cigna-Express Scripts Deal

Proxy-advisory firm Institutional Shareholder Services is recommending that Cigna shareholders support the company’s $54 billion deal to buy pharmacy-benefit manager Express Scripts in a vote later this month......»»

Category: smallbizSource: wsjAug 10th, 2018

Key shareholder adviser backs Cigna-Express Scripts deal

Cigna's plan to buy pharmacy benefit manager Express Scripts for around $52 billion has received a big endorsement a few days after activist investor Carl Icahn urged shareholders to reject it......»»

Category: topSource: foxnewsAug 10th, 2018

Icahn Backs Down on Cigna-Express Scripts Deal

Carl Icahn no longer plans to solicit votes from Cigna shareholders against the health-insurer’s $54 billion deal to buy Express Scripts after two proxy-advisory firms recommended shareholders support the deal......»»

Category: smallbizSource: wsjAug 13th, 2018

New filing reveals Cigna"s plans for Express Scripts

Express Scripts will remain in St. Louis following the company's sale to Connecticut-based Cigna, according to a securities filing Wednesday. The $67 billion deal was announced in March and is expected to close before the end of the year. The Express S.....»»

Category: topSource: bizjournalsMay 17th, 2018

Cigna-Express Scripts: Analysis Of Each Stock And Of The Deal

Cigna-Express Scripts: Analysis Of Each Stock And Of The Deal.....»»

Category: topSource: seekingalphaJun 11th, 2018

Icahn built stake in Cigna, to vote against Express Scripts deal, WSJ says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 1st, 2018

Technical Take: Express Scripts drops as Icahn said to oppose Cigna deal

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 1st, 2018

Icahn To Attempt To Block Cigna-Express Scripts Deal With Recent Stake

Activist investor Carl Icahn has accrued a stake in CIGNA Corporation (NYSE: CI) that he intends to leverage to block the Express Scripts Holding Co (NASDAQ: ESRX) merger, according to a Wednesday report from the read more.....»»

Category: blogSource: benzingaAug 1st, 2018

Carl Icahn Plans to Vote Against Express Scripts Deal

Activist investor Carl Icahn has built a sizable stake in Cigna and plans to vote against the health insurer’s $54 billion planned purchase of Express Scripts......»»

Category: smallbizSource: wsjAug 2nd, 2018

Cigna investor Carl Icahn plans to vote against Express Scripts deal, WSJ says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 2nd, 2018

Cigna holders unlikely to vote down Express Scripts deal, says JPMorgan

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 2nd, 2018

Carl Icahn to Publicly Oppose $54 Billion Cigna-Express Scripts Deal

Carl Icahn is going public with his campaign to scuttle Cigna Corp.’s $54 billion plan to buy Express Scripts Holding Co......»»

Category: smallbizSource: wsjAug 6th, 2018

Icahn to send letter to oppose Cigna-Express Scripts deal: WSJ

Investor Carl Icahn will send an open letter to the shareholders of insurer Cigna Corp asking them to vote against the company's $52 billion Express Scripts Holding Co buyout, the Wall Street Journal reported on Monday, citing a draft of the letter......»»

Category: topSource: reutersAug 6th, 2018

Icahn to Publicly Oppose $54 Billion Cigna-Express Scripts Deal

Carl Icahn is going public with his campaign to scuttle Cigna Corp.’s $54 billion plan to buy Express Scripts Holding Co......»»

Category: smallbizSource: wsjAug 7th, 2018

Icahn urges Cigna shareholders to vote against Express Scripts deal

Billionaire investor Carl Icahn on Tuesday urged Cigna Corp shareholders to vote against the health insurer's $52 billion acquisition of Express Scripts Holding Co ......»»

Category: topSource: reutersAug 7th, 2018

Icahn Publicly Opposes $54 Billion Cigna-Express Scripts Deal

Carl Icahn is going public with his campaign to scuttle Cigna Corp.’s $54 billion plan to buy Express Scripts Holding Co......»»

Category: smallbizSource: wsjAug 7th, 2018

Icahn highlights Amazon threat in bid to block Cigna-Express Scripts deal

Activist investor Carl Icahn on Tuesday urged Cigna Corp shareholders to vote against the health insurer's $52 billion purchase of Express Scripts Holding Co , citing regulatory hurdles and the growing threat of Amazon......»»

Category: topSource: reutersAug 7th, 2018

Carl Icahn: Cigna"s merger with Express Scripts rivals "worst in corporate history"

Activist investor Carl Icahn is urging other Cigna shareholders to vote against its deal to buy Express Scripts,.....»»

Category: topSource: moneycentralAug 7th, 2018

Icahn goes public with opposition to Express Scripts-Cigna deal

Billionaire investor Carl Icahn is going public with his opposition to the $54 billion Express Scripts-Cigna merger, calling it a "folly" with a "ridiculous" price tag. "Cigna is dramatically overpaying for a highly challenged Express Scripts that is.....»»

Category: topSource: bizjournalsAug 7th, 2018

Amazon pharmacy should derail 'ridiculous' Cigna, Express Scripts deal, Carl Icahn says

Amazon's budding entry into the online prescription business is one of several reasons why shareholders should reject health insurer Cigna's proposed acqui.....»»

Category: topSource: usatodayAug 7th, 2018